In Vitro Effects of Antimicrobial Agents on Planktonic and Biofilm Forms of Staphylococcus lugdunensis Clinical Isolates
- 1 March 2007
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 51 (3) , 888-895
- https://doi.org/10.1128/aac.01052-06
Abstract
Staphylococcus lugdunensis is an atypically virulent coagulase-negative staphylococcal species associated with acute and destructive infections that often resemble Staphylococcus aureus infections. Several types of infection caused by S. lugdunensis (e.g., native valve endocarditis, prosthetic joint infection, and intravascular catheter infection) are associated with biofilm formation, which may lead to an inability to eradicate the infection due to the intrinsic nature of biofilms to resist high levels of antibiotics. In this study, planktonic MICs and MBCs and biofilm bactericidal concentrations of 10 antistaphylococcal antimicrobial agents were measured for 15 S. lugdunensis isolates collected from patients with endocarditis, medical device infections, or skin and soft tissue infections. Planktonic isolates were susceptible to all agents studied, but biofilms were resistant to high concentrations of most of the drugs. However, moxifloxacin was able to kill 73% of isolates growing in biofilms at </=0.5 mug/ml. Relative to the effect on cell density, subinhibitory concentrations of nafcillin substantially stimulated biofilm formation of most isolates, whereas tetracycline and linezolid significantly decreased biofilm formation in 93 and 80% of isolates, respectively. An unexpected outcome of MBC testing was the observation that vancomycin was not bactericidal against 93% of S. lugdunensis isolates, suggesting widespread vancomycin tolerance in this species. These data provide insights into the response of S. lugdunensis isolates when challenged with various levels of antimicrobial agents in clinical use.Keywords
This publication has 71 references indexed in Scilit:
- Tolerance to the Glycopeptides Vancomycin and Teicoplanin in Coagulase-Negative StaphylococciAntimicrobial Agents and Chemotherapy, 2007
- Multiple combination antibiotic susceptibility testing of nontypeable Haemophilus influenzae biofilmsPublished by Elsevier ,2006
- Effects of Growth in the Presence of Subinhibitory Concentrations of Dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus BiofilmsApplied and Environmental Microbiology, 2005
- Infections Associated with Medical DevicesDrugs, 2005
- A fibrinogen-binding protein ofStaphylococcus lugdunensisFEMS Microbiology Letters, 2004
- A von Willebrand factor-binding protein fromStaphylococcus lugdunensisFEMS Microbiology Letters, 2004
- Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysisDiagnostic Microbiology and Infectious Disease, 2004
- Staphylococcus lugdunensis Endocarditis?The Hidden Peril of Coagulase-Negative Staphylococcus in Blood CulturesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Prosthetic Joint Infection Due to Staphylococcus lugdunensisMayo Clinic Proceedings, 2000
- Endocarditis Due to Staphylococcus lugdunensis: Report of 11 Cases and ReviewClinical Infectious Diseases, 1993